Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
top of page
Companies in the News
Acquisition transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end...
- Feb 6
Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
Initial studies will focus on infants and young children; company plans to begin clinical trials in the United States and Australia in...
- Dec 8, 2023
eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion
Median progression free survival (mPFS) of 7.4 months in the ZFA expansion cohort evaluating zotatifin in combination with fulvestrant...
- Sep 28, 2023
Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study
10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike...
- Sep 14, 2023
Generate:Biomedicines Announces Close of $273M Series C Financing
Funding will advance pipeline of 17 existing programs and approximately 10 new starts annually Company has raised nearly $700 million in...
- Jun 20, 2023
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc....
- May 22, 2023
EBR Systems' Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results
Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug...
- Apr 27, 2023
Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement
Multi-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways...
- Apr 13, 2023
Sana Biotechnology Announces Preclinical Data Published in Nature Communications
Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic...
bottom of page